RNA, 5S ribosomal pseudogene 533 (RNA5SP533)

RNA, 5S ribosomal pseudogene 533 (RNA5SP533) is a member of the pseudogene family, specifically categorized as a 5S ribosomal RNA pseudogene[1][7]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations, lack of regulatory elements, or other genomic changes[7]. RNA5SP533 is not expected to encode a functional protein or RNA molecule and is not recognized as a bona fide therapeutic target, receptor, enzyme, transporter, or similar molecule. Rather, like many pseudogenes, it may be transcriptionally silent or expressed at low levels without clear biological function[1][5]. Some pseudogenes can take on regulatory roles at the RNA level, such as acting as decoys or sponges for microRNAs (miRNA), producing small interfering RNAs (siRNAs), or influencing the expression of related genes[5][3]. There is no evidence indicating RNA5SP533 has a defined such role, nor any implication in human disease, therapeutic development, or as a biomarker. RNA5SP533 has not been reported as being targeted by drugs or serving as a molecular target in clinical or experimental therapy[1]. Thus, RNA5SP533 is a pseudogene that does not meet criteria for a canonical therapeutic target, lacks established molecular or disease roles, and has no accepted therapeutic or diagnostic utility[1][5][7]. Notes on incorrectness: - RNA5SP533 is a pseudogene, not a functional receptor, enzyme, transporter, transcription factor, or similar target. - It is not a validated or widely recognized drug target. - There is no evidence of disease association, drug interactions, or biomarker value. Summary of key points: - RNA5SP533 is best described as a 5S ribosomal RNA pseudogene. - It is not a therapeutic target. - Common alias: RNA5SP533. - Classified under pseudogene, non-coding RNA, other. - No established biological or disease-related function, druggability, or safety profile[1][3][5][7].

Other names

RNA5SP533